Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Mapping Neurodegeneration with Spatial Glycoproteomics 
Mass Spectrometry Proteomics News and Research Clinical

Mapping Neurodegeneration with Spatial Glycoproteomics 

Combined proteomic and glycomic profiling reveals molecular signatures of Alzheimer’s and Lewy body disease 

03/16/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Quiz
  • Poll
  • Top Institutions

Share

Top Institutions in Neurodegeneration and Spatial Glycoproteomics

Leading institutions employ cutting-edge spatial mass spectrometry workflows, combining enzymatic digestion on tissue slides with liquid chromatography data-independent acquisition tandem mass spectrometry (LC-DIA-MS/MS) to achieve high-resolution molecular profiling of brain tissue. These approaches enable detailed analysis of glycoproteins and extracellular matrix remodeling implicated in neurodegeneration, supporting biomarker discovery and therapeutic development.

  • #1

    Boston University Chobanian & Avedisian School of Medicine

    Boston, MA

    Pioneers in developing spatial glycoproteomics workflows combining on-slide enzymatic digestion with LC-DIA-MS/MS to map neurodegenerative molecular changes at high resolution, with demonstrated application in Alzheimer's and Lewy body disease.

    Key Differentiators

    • Neurodegeneration
    • Mass Spectrometry
    • Proteomics
    • Glycomics
  • #2

    Massachusetts Institute of Technology (MIT) - Koch Institute for Integrative Cancer Research

    Cambridge, MA

    Leads in developing advanced mass spectrometry technologies and spatial proteomics methods with applications in neurodegenerative disease research, integrating engineering and biological insights.

    Key Differentiators

    • Mass Spectrometry
    • Neurobiology
    • Proteomics
  • #3

    Johns Hopkins University School of Medicine

    Baltimore, MD

    Renowned for comprehensive neurodegenerative disease research integrating proteomic and glycomic analyses to elucidate molecular mechanisms underlying Alzheimer's and related disorders.

    Key Differentiators

    • Neurodegeneration
    • Proteomics
    • Neuropathology
  • #4

    Stanford University School of Medicine

    Stanford, CA

    Integrates spatial proteomics and glycomics with neurodegenerative disease models, leveraging advanced mass spectrometry and imaging technologies to study brain aging and pathology.

    Key Differentiators

    • Neuroscience
    • Mass Spectrometry
    • Proteomics
  • #5

    University of California, San Diego (UCSD) School of Medicine

    San Diego, CA

    Known for integrating glycoproteomics and extracellular matrix research in neurodegenerative diseases, with strong clinical and translational neuroscience programs.

    Key Differentiators

    • Neurodegeneration
    • Proteomics
    • Glycomics

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

 This Week’s Mass Spec News
Mass Spectrometry
This Week’s Mass Spec News

April 4, 2025

2 min read

 What If Computers Could Smell?
Mass Spectrometry
What If Computers Could Smell?

April 3, 2025

13 min read

Computers can “see” and “hear,” but fully digitizing scent has so far eluded science – but that may soon change

The Analytical Scientist Innovation Awards 2024: #6
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #6

December 3, 2024

3 min read

Syft Technologies’ William Pelet introduces the Syft Explorer – the world's first fully mobile, real-time, and direct trace gas analyzer

The Analytical Scientist Innovation Awards 2024: #4
Mass Spectrometry
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.